CiToxLAB Group Increases Revenue by 25 Per Cent over Full Year of 2012

News   Feb 21, 2013

 
CiToxLAB Group Increases Revenue by 25 Per Cent over Full Year of 2012
 
 
 

RELATED ARTICLES

Human Minibrains reveal the Effects of Psychedelic Substances

News

By employing mass spectrometry-based proteomics to analyze cerebral organoids, scientists identified the effects of psychedelic substances in the brain.

READ MORE

Osteoporosis Treatments Advanced by Mass Spectrometry Techniques

News

Using advanced mass spectrometry technology, scientists have developed a molecular model that may provide a new framework for improving the design of osteoporosis treatments.

READ MORE

Biomedical Catalyst Award Goes To BioMoti, Pharmidex and Queen Mary University of London

News

The grant was awarded under the Biomedical Catalyst funding competition to support preclinical studies of new therapeutic approaches for hard-to-treat tumours including advanced ovarian, triple negative breast and pancreatic cancers.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Analysis & Separations Biopharma Cell Science Drug Discovery Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE